We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drive to Develop Trial Data Standards Has NDA, BLA Implications
FDA Drive to Develop Trial Data Standards Has NDA, BLA Implications
October 25, 2013
The FDA has released a plan detailing how the agency will develop and implement clinical trial data terminology standards for therapeutic areas (TA), an initiative that could affect drug and biologic application reviews.